Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25435289 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25436110 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL31546363 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25402463 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25435085 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25402468 | 0.90 | MEN1 (0.48) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25439279 | 0.89 | MAPT (0.52) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25439629 | 0.89 | MAPT (0.52) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25433029 | 0.89 | MEN1 (0.67) | MAPTLMNAMEN1KMT2APOLB | |
| SCHEMBL25439278 | 0.89 | MAPT (0.52) | MAPTLMNAMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |